Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Cabrera-Socorro, Alfredo  [Clear All Filters]
2022
Kwok CKeong, Sébastien I, Hariharan K, Meiser I, Wihan J, Altmaier S, Karnatz I, Feile A, Cabrera-Socorro A, Rasmussen M, et al. Scalable expansion of iPSC and their derivatives across multiple lineages. Reprod Toxicol. 2022.
2021
Shih P-Y, Kreir M, Kumar D, Seibt F, Pestana F, Schmid B, Holst B, Clausen C, Steeg R, Fischer B, et al. Development of a fully human assay combining NGN2-inducible neurons co-cultured with iPSC-derived astrocytes amenable for electrophysiological studies. Stem Cell Res. 2021;54:102386.
Steeg R, Mueller SC, Mah N, Holst B, Cabrera-Socorro A, Stacey GN, de Sousa PA, Courtney A, Zimmermann H. EBiSC best practice: How to ensure optimal generation, qualification, and distribution of iPSC lines. Stem Cell Reports. 2021;16(8):1853-1867.
Schmid B, Holst B, Clausen C, Bahnassawy L, Reinhardt P, Bakker MHM, Díaz-Guerra E, Vicario C, Martino-Adami PV, Thoenes M, et al. Generation of a set of isogenic iPSC lines carrying all APOE genetic variants (Ɛ2/Ɛ3/Ɛ4) and knock-out for the study of APOE biology in health and disease. Stem Cell Res. 2021;52:102180.
2020
Schmid B, Prehn KR, Nimsanor N, Garcia BIrene Alda, Poulsen U, Jørring I, Rasmussen MA, Clausen C, Mau-Holzmann UA, Ramakrishna S, et al. Corrigendum to "Generation of a set of isogenic, gene-edited iPSC lines homozygous for all main APOE variants and an APOE knock-out line" [Stem Cell Res. 34/1873-5061 (2019) 101349-55]. Stem Cell Res. 2020;48:102005.
2019
Hirose T, Cabrera-Socorro A, Chitayat D, Lemonnier T, Féraud O, Cifuentes-Diaz C, Gervasi N, Mombereau C, Ghosh T, Stoica L, et al. ATP6AP2 variant impairs CNS development and neuronal survival to cause fulminant neurodegeneration. J Clin Invest. 2019;130.
Schmid B, Prehn KR, Nimsanor N, Garcia BIrene Alda, Poulsen U, Jørring I, Rasmussen MA, Clausen C, Mau-Holzmann UA, Ramakrishna S, et al. Generation of a set of isogenic, gene-edited iPSC lines homozygous for all main APOE variants and an APOE knock-out line. Stem Cell Res. 2019;34:101349.
Verheyen A, Diels A, Reumers J, Van Hoorde K, Van Den Wyngaert I, d'Ydewalle Cvan Outryv, De Bondt A, Kuijlaars J, De Muynck L, De Hoogt R, et al. Genetically Engineered iPSC-Derived FTDP-17 MAPT Neurons Display Mutation-Specific Neurodegenerative and Neurodevelopmental Phenotypes. Stem Cell Reports. 2019;13(2):434-435.
2018
García-León JAntonio, Cabrera-Socorro A, Eggermont K, Swijsen A, Terryn J, Fazal R, Nami FA, Ordovas L, Quiles A, Lluis F, et al. Generation of a human induced pluripotent stem cell-based model for tauopathies combining three microtubule-associated protein tau mutations which displays several phenotypes linked to neurodegeneration. Alzheimers Dement. 2018.